Data from this study are available on the Odum Institute, HIV self-testing Dataverse: <http://dx.doi.org/10.15139/S3/12409>.

Introduction {#sec008}
============

Low uptake of HIV testing services in sub-Saharan Africa (SSA) is among the key barriers to meeting the 90-90-90 targets established by UNAIDS and to improving the effectiveness of HIV treatment as prevention. HIV testing among men in particular remains low in many countries, as does knowledge of HIV status among HIV-infected persons \[[@pmed.1002166.ref001]\]. Door-to-door testing and mobile testing strategies have moved testing services out of health facilities and into communities, overcoming barriers related to clinic-based testing and, subsequently, increasing testing coverage. However, despite these advancements, there remains a need for novel interventions that can promote testing among men and other hard-to-reach populations \[[@pmed.1002166.ref002],[@pmed.1002166.ref003]\].

In addition to increasing HIV testing uptake among men, achieving higher rates of couples testing can also contribute to HIV prevention efforts. Low uptake of couples testing is particularly concerning in light of data indicating that four out of every ten new HIV infections occur within stable heterosexual partnerships and that the majority of persons in sero-discordant relationships are unaware of their HIV status \[[@pmed.1002166.ref004]\]. The benefits of couples testing may include safer sexual behavior in couples \[[@pmed.1002166.ref005]\], higher uptake of interventions such as antiretroviral therapy (ART) for HIV-positive partners \[[@pmed.1002166.ref006]\], and pre-exposure prophylaxis (PrEP) among HIV-negative partners in sero-discordant relationships, as well as increased uptake of and adherence to prevention of mother-to-child transmission (PMTCT) interventions \[[@pmed.1002166.ref007]--[@pmed.1002166.ref009]\]. Given the need to achieve better PMTCT outcomes and prevent new infections in couples, a number of countries have sought to promote partner testing and couples testing among pregnant and postpartum women \[[@pmed.1002166.ref010]\]. However, efforts to encourage pregnant and postpartum women to refer their male partners for HIV testing have had limited success \[[@pmed.1002166.ref011],[@pmed.1002166.ref012]\]. The barriers to testing among male partners have included stigma, fear of prognosis, lack of awareness of HIV risk, inconvenience, fear of disclosure, transportation costs, opportunity costs such as time off from work, and behavioral factors such as a tendency to delay behaviors with immediate costs and delayed benefits \[[@pmed.1002166.ref013],[@pmed.1002166.ref014]\].

HIV self-testing (HIVST) is a promising approach that addresses many barriers associated with clinic-based HIV testing and has had high acceptability in SSA \[[@pmed.1002166.ref015]--[@pmed.1002166.ref017]\]. Self-tests enable individuals to test themselves for HIV privately and at their own convenience. Simple oral-fluid-based tests have achieved high sensitivity and specificity, with some studies also having shown that the tests can be used accurately by individuals \[[@pmed.1002166.ref018]\]. A number of countries in SSA have developed policies for implementation and support of HIVST \[[@pmed.1002166.ref019],[@pmed.1002166.ref020]\], with Kenya being the first country in SSA to include HIVST in its national testing guidelines \[[@pmed.1002166.ref021]\]. Recent research in Kenya has also demonstrated the acceptability and feasibility of a novel "secondary distribution" strategy that seeks to promote HIV testing among men and in couples through provision of multiple self-tests to women seeking health services \[[@pmed.1002166.ref022]\].

We conducted a randomized trial in Kenya among women receiving antenatal care (ANC) or postpartum care (PPC) services to test whether the provision of multiple self-tests to women for distribution to their partners can increase uptake of male partner testing and couples testing.

Methods {#sec009}
=======

Ethics Statement {#sec010}
----------------

The study received approval from the Scientific and Ethics Review Unit at the Kenya Medical Research Institute and the Office of Human Research Ethics at the University of North Carolina at Chapel Hill.

Study Setting {#sec011}
-------------

The study was conducted in urban and peri-urban areas within Kisumu County, Kenya. Adult HIV prevalence in Kisumu County is 19.3% \[[@pmed.1002166.ref023]\], the third highest among the counties in the country. Women visiting ANC and PPC clinics were recruited from three health facilities in Kisumu.

Study Design and Participants {#sec012}
-----------------------------

Trained research assistants screened and enrolled women seeking ANC or PPC at the three facilities, in a private location away from regular clinic activities. Women were given the opportunity to enroll in the study if they met the following eligibility criteria: were 18--39 y of age, reported that their primary partner was not known to be HIV-positive or had not tested in the past 6 mo, resided in or around Kisumu County, and had no intention of leaving the area within 3 mo. In addition, at the ANC clinic eligibility was limited to women with gestation age ≤ 20 wk, and at the PPC clinic eligibility was limited to women who had given birth in the past 6 wk to 12 mo. Following the provision of written informed consent, participants were administered a baseline questionnaire that measured demographic characteristics, sexual behavior, HIV testing history, and partner characteristics. All study staff received ethical training on research with human participants.

Randomization Procedures {#sec013}
------------------------

Participants were randomized in a 1:1 ratio using balanced block randomization (block size 20) to an HIVST group or a comparison group. Sealed randomization envelopes were offered to participants sequentially, and these revealed the study group assignment to the participant and study staff simultaneously.

Intervention {#sec014}
------------

Participants in the HIVST group received two oral-fluid-based rapid HIV tests (OraQuick Rapid HIV-1/2 Antibody Test, OraSure Technologies). Each test was accompanied with an instruction sheet that described step-by-step self-testing procedures in multiple languages. Study staff also provided the participants with a brief demonstration of how to use the test. Participants were encouraged to distribute a test kit to their male partner or to use both test kits to undertake couples testing if they felt comfortable doing so; they were also counseled on how to talk to their partners about HIV testing, the possibility of adverse reactions associated with suggesting HIV testing to their partner, learning their partner's HIV status, and disclosing their own HIV status. Following Kenya's 2015 HIV testing services guidelines \[[@pmed.1002166.ref019]\], participants were informed about the need to seek clinic-based confirmatory testing if a positive (reactive) self-test result was obtained, and an invitation card for confirmatory testing at a clinic in the study area was included with each test.

Participants in the comparison group were counseled on the importance of partner testing and provided with an invitation card to give to their partner for HIV testing at a study clinic. The use of invitation cards to promote male partner testing is currently standard practice in many facilities. The cards mentioned the importance of testing, listed the health facility where the participant was enrolled, and encouraged the male partner to get tested at the study facility.

Both groups received information on where to seek advice and assistance for clinical, counseling, and legal support in case of intimate partner violence (IPV). They also were given a study phone number to call in case they had questions or needed advice about clinic-based testing or self-testing, or IPV or other adverse events.

Follow-Up Assessments {#sec015}
---------------------

Follow-up data collection occurred over a 3-mo period. Participants were contacted each month to determine if they had distributed a self-test kit to their sexual partner (HIVST group) or if their partner had sought HIV testing at a clinic (comparison group). Research assistants scheduled and conducted an in-person follow-up interview with participants who reported having distributed a test to their partner or who reported that their partner sought clinic-based testing, while participants who had not done so or were not reached at 1 and 2 mo were interviewed at 3 mo. If participants were unable to meet with research assistants, a follow-up phone interview was conducted. Participants in both groups were asked whether their partner had been tested for HIV since study enrollment.

Statistical Analyses {#sec016}
--------------------

The unit of analysis was the study participant. All outcomes were self-reported by study participants. The primary, prespecified outcome was whether the primary partner of the participant had an HIV test within 3 mo of enrollment, which was determined from the follow-up survey question: "Has your partner had an HIV test since you were enrolled in the study?" The primary analysis compared this outcome in the HIVST and comparison groups using an unadjusted modified Poisson regression with robust standard errors \[[@pmed.1002166.ref024]\]. Our original analysis plan proposed estimation of a logistic regression model, but ultimately we selected a modified Poisson model because risk ratios can be easier to interpret than odds ratios. We chose to present both the absolute risk differences between the two study groups and the risk ratios from modified Poisson regressions. Participants who were not successfully followed up were not included in the analyses as it was not possible to determine the primary and secondary outcomes for them.

In secondary analyses we examined the impact of the intervention on the following six outcomes reported by participants: (1) discussion of HIV testing with partner, (2) couples testing, (3) couples testing among participants whose partner tested for HIV, (4) awareness of partner's HIV test result, (5) awareness of partner's HIV test result among participants whose partner tested for HIV, and (6) partner's HIV test result. Discussion of HIV testing was defined as having occurred if the participant reported that she and her partner had talked about HIV testing since enrollment in the study. Couples testing was defined as having occurred when a participant reported that she had tested together with her partner at the same time. Awareness of partner's HIV test result was defined as the participant having learned her partner's HIV status. Additionally, we examined whether partners of participants in the HIVST group who tested positive sought confirmatory testing and whether partners in both groups who received a positive result were reported to be in care at the time of follow-up. We also assessed IPV at baseline and follow-up using questions adapted from the Kenya Demographic and Health Survey \[[@pmed.1002166.ref025]\] that asked whether participants experienced physical, emotional, verbal, or sexual violence from their partner. Participants were coded as having experienced IPV if they responded affirmatively to any of the IPV questions. Survey questions used to measure study outcomes are reported in [S1 Table](#pmed.1002166.s001){ref-type="supplementary-material"}.

In order to determine whether there were differences in intervention effectiveness in certain populations, we estimated modified Poisson regression models among participants who were enrolled at each of the three health facilities, among those whose primary partner had tested for HIV in the 12 mo prior to enrollment or not, and among those who had experienced IPV in the 12 mo prior to enrollment or not. All statistical tests were two-sided, and significance level was set at *p* \< 0.05. No adjustment was made for multiple testing since the secondary analyses were considered exploratory. Statistical analyses were performed using Stata 14.1.

The planned sample size for the study was 600, with 300 participants in each study group. Power calculations assuming a two-sided unadjusted independent proportions test indicated that with a sample size of 300 per study group and 20% uptake of partner testing in the comparison group, there would be 80% power to detect a difference in partner testing as small as 10%.

Results {#sec017}
=======

Participant Recruitment and Flow {#sec018}
--------------------------------

Between June 11, 2015, and October 16, 2015, a total of 1,929 women were screened for participation. Among those, 614 (32%) were determined to be ineligible, 715 declined to participate (37%), and 600 (31%) were enrolled and randomized ([Fig 1](#pmed.1002166.g001){ref-type="fig"}). Reasons for ineligibility included no primary partner (28%), partner HIV-positive (22%), intention of leaving study area during follow-up period (15%), age of participant (8%), age of child (8%), and fear of IPV due to discussing HIV testing with partner (5%). Common reasons for refusal included women reporting they were "in a hurry" or "too busy" (384/715, 53.7%), needing permission from partner to enroll in a study (54/715, 7.6%), and reporting their partner had tested recently and therefore did not have interest in participating in the study (111/715, 15.5%). Follow-up interviews were conducted until January 15, 2016. One person from the comparison group withdrew from the study during the follow-up period. Of the 600 participants who were enrolled, follow-up was completed for 570 (95%), 286 (94.4%) in the comparison group and 284 (95.6%) in the HIVST group.

![Assessment of eligibility, randomization, and follow-up.\
HIVST, HIV self-testing.](pmed.1002166.g001){#pmed.1002166.g001}

Participant Characteristics {#sec019}
---------------------------

Participants in the two study groups had largely similar characteristics at baseline ([Table 1](#pmed.1002166.t001){ref-type="table"}). Their mean age was 24 y, and the vast majority were married. Median monthly earnings was US\$0 since the majority did not report any engagement in income-earning activities during or after pregnancy. Participants' self-reported sexual behavior and their reports of their partner's HIV testing history were similar in both groups ([Table 2](#pmed.1002166.t002){ref-type="table"}). Nearly 4% of all participants self-reported being HIV-positive. The majority of participants reported that their partner had tested for HIV in the past 12 mo (56%), and only a small percentage of participants (14%) had heard of HIVST prior to the study. Nearly 30% of participants reported experiencing IPV in the past 12 mo.

10.1371/journal.pmed.1002166.t001

###### Baseline characteristics of study participants.

![](pmed.1002166.t001){#pmed.1002166.t001g}

  Characteristic                                    Comparison Group (*n =* 286)   HIV Self-Testing Group (*n =* 284)   Total (*n =* 570)
  ------------------------------------------------- ------------------------------ ------------------------------------ -------------------
  **Age (years), mean (SD)**                        24.2 (4.3)                     24.2 (4.5)                           24.2 (4.4)
  **Monthly earnings (US dollars), median (IQR)**   0 (0--30)                      0 (0--40)                            0 (0--36)
  **Ethnic group**                                                                                                      
  Luo                                               221 (77)                       219 (77)                             440 (77)
  Luhya                                             33 (12)                        43 (15)                              76 (13)
  Other                                             32 (11)                        22 (8)                               54 (9)
  **Education**                                                                                                         
  Some or completed primary                         138 (48)                       143 (50)                             281 (49)
  Some secondary                                    133 (47)                       120 (42)                             253 (44)
  Completed secondary or greater                    15 (5)                         21 (7)                               36 (6)
  **Married**                                       266 (93)                       266 (94)                             532 (93)
  **Occupation**                                                                                                        
  Non-manual                                        74 (26)                        83 (29)                              157 (28)
  Manual                                            19 (7)                         28 (10)                              47 (8)
  Housewife/unemployed                              193 (67)                       173 (61)                             366 (64)

For all variables frequencies are presented, with percentages in parentheses, except where otherwise noted.

IQR, interquartile range; SD, standard deviation.

10.1371/journal.pmed.1002166.t002

###### Self-reported sexual behavior and HIV testing history.

![](pmed.1002166.t002){#pmed.1002166.t002g}

  Behavior or HIV Testing History                                        Comparison Group (*n =* 286)   HIV Self-Testing Group (*n =* 284)   Total, (*n =* 570)
  ---------------------------------------------------------------------- ------------------------------ ------------------------------------ --------------------
  **Age at first intercourse (years), mean (SD)**                        17.7 (2.8)                     17.9 (2.5)                           17.8 (2.7)
  **Condom used during last sex**                                        54 (19)                        46 (16)                              100 (18)
  **Had at least one other sexual partner in the past 12 mo**            4 (1)                          5 (2)                                9 (2)
  **Number of times been tested for HIV in the past 12 mo, mean (SD)**   2.8 (1.4)                      2.8 (1.5)                            2.8 (1.4)
  **Self-reported HIV-positive**                                         10 (3.5)                       13 (4.6)                             23 (4.1)
  **Heard of HIV self-testing prior to study**                           39 (14)                        41 (14)                              80 (14)
  **Primary partner ever tested for HIV**                                                                                                    
  Yes                                                                    220 (77)                       216 (76)                             436 (76)
  No                                                                     19 (7)                         21 (7)                               40 (7)
  Don't know                                                             47 (16)                        47 (17)                              94 (16)
  **Primary partner tested for HIV in the past 12 mo**                                                                                       
  Yes                                                                    173 (60)                       149 (52)                             322 (56)
  No                                                                     35 (12)                        42 (15)                              77 (14)
  Don't know                                                             78 (27)                        93 (33)                              171 (30)
  **Know partner's status**                                              192 (67)                       194 (68)                             386 (68)
  **Experienced intimate partner violence in the past 12 mo**            76 (27)                        78 (27)                              154 (27)

For all variables frequencies are presented, with percentages in parentheses, except where otherwise noted.

SD, standard deviation.

Male Partner Testing {#sec020}
--------------------

Male partner testing within 3 mo of enrollment was higher in the HIVST group (258/284, 90.8%) than the comparison group (148/286, 51.7%), as shown in [Table 3](#pmed.1002166.t003){ref-type="table"}. The difference of 39.1% between the two groups was statistically significant (95% CI 32.4% to 45.8%, *p \<* 0.001). Among participants in the HIVST group whose partners used a self-test, 76% and 17% reported that their partner found it "very easy" or "somewhat easy," respectively, to use the self-test, while 6% reported that their partner found it "somewhat difficult" or "very difficult." In the comparison group, 45% (67/148) of partners who tested were reported to have done so outside of the three study facilities.

10.1371/journal.pmed.1002166.t003

###### Effects of HIV self-testing intervention within 3 mo.

![](pmed.1002166.t003){#pmed.1002166.t003g}

   Outcome                                                                                                         Comparison Group, Number (Percent) (*n =* 286)   HIV Self-Testing Group, Number (Percent) (*n =* 284)   Absolute Difference, Percentage Points (95% CI)[\*](#t003fn001){ref-type="table-fn"}   Risk Ratio (95% CI)[\*\*](#t003fn002){ref-type="table-fn"}   *p*-Value[\*](#t003fn001){ref-type="table-fn"}
  ---------------------------------------------------------------------------------------------------------------- ------------------------------------------------ ------------------------------------------------------ -------------------------------------------------------------------------------------- ------------------------------------------------------------ ------------------------------------------------
  **Primary outcome**                                                                                                                                                                                                                                                                                                                                                          
  Male partner HIV testing                                                                                         148 (51.7)                                       258 (90.8)                                             39.1 (32.4 to 45.8)                                                                    1.76 (1.56--1.98)                                            \<0.001
  **Secondary outcomes**                                                                                                                                                                                                                                                                                                                                                       
  Discussed HIV testing with partner                                                                               276 (96.5)                                       271 (95.4)                                             −1.1 (−4.3 to 2.2)                                                                     0.99 (0.96--1.02)                                            0.512
  Couples testing for HIV                                                                                          95 (33.2)                                        214 (75.4)                                             42.1 (34.7 to 49.6)                                                                    2.27 (1.90--2.71)                                            \<0.001
  Couples testing conditional on partner HIV testing[\*\*\*](#t003fn003){ref-type="table-fn"}                      95 (64.2)                                        214 (82.9)                                             18.8 (9.8 to 27.8)                                                                     1.29 (1.13--1.48)                                            \<0.001
  Aware of partner's HIV test result                                                                               145 (50.7)                                       255 (89.8)                                             39.1 (32.3 to 45.9)                                                                    1.77 (1.57--2.00)                                            \<0.001
  Aware of partner's HIV test result conditional on partner HIV testing[\*\*\*](#t003fn003){ref-type="table-fn"}   145 (98.0)                                       255 (98.8)                                             0.9 (−1.8 to 3.5)                                                                      1.01 (0.98--1.04)                                            0.519
  Partner tested HIV-positive                                                                                      4 (1.4)                                          8 (2.8)                                                1.4 (−0.9 to 3.8)                                                                      2.01 (0.61--6.62)                                            0.239

\*Estimates and confidence intervals are marginal effects from unadjusted modified Poisson regression.

\*\*Estimates and confidence intervals are risk ratios from unadjusted modified Poisson regression.

\*\*\*Model includes the subset of participants whose partner tested for HIV.

Secondary Outcomes {#sec021}
------------------

Over 95% of participants in both groups reported discussing HIV testing with their partner since enrollment, and there was no significant difference between the two groups (difference = −1.1%, 95% CI −4.3% to 2.2%, *p* = 0.512). Participants in the HIVST group were more likely to test as a couple than participants in the comparison group (difference = 42.1%, 95% CI 34.7% to 49.6%, *p \<* 0.001). In addition, among participants whose partner tested for HIV during the follow-up period, couples testing was more likely in the HIVST group than the comparison group (difference = 18.8%, 95% CI 9.8% to 27.8%, *p \<* 0.001).

At follow-up, participants in the HIVST group were more likely to know their partner's HIV status than those in the comparison group (difference = 39.1%, 95% CI 32.4% to 45.8%, *p \<* 0.001). However, among participants whose partner tested for HIV during the follow-up period, participants' awareness of their partner's HIV status did not differ significantly between the two groups (difference = 0.9%, 95% CI −1.8% to 3.5%, *p \<* 0.519), suggesting that the increase in awareness of partner HIV status in the HIVST group was driven by the greater likelihood of partner testing having occurred rather than a greater likelihood of becoming aware if a partner did get tested. Among participants whose partner tested for HIV, almost all were aware of their partner's HIV test result (98.0% in comparison group, 98.8% in HIVST group). A small number of participants in both groups reported that their partner tested HIV-positive (1.4% in comparison group, 2.8% in HIVST group). Among the eight partners who tested positive in the HIVST group, two went for confirmatory testing, were confirmed positive, and were linked to care. Among the four partners who tested positive in the comparison group, three were reported to have sought HIV care at the time of the 3-mo interview. No participants in either group reported IPV due to HIV testing.

Heterogeneity of Intervention Effectiveness {#sec022}
-------------------------------------------

Participants in the HIVST group reported higher partner testing rates than participants in the comparison group in all subgroups examined ([Table 4](#pmed.1002166.t004){ref-type="table"}). While partner testing was significantly more likely in the HIVST group than the comparison group in all three study sites, the HIVST intervention was more effective in promoting partner testing in the hospital setting as compared to the urban health clinic setting (*p \<* 0.001). There was no difference in intervention effectiveness by partner testing status in the past 12 mo (*p* = 0.172). Similarly, we found no difference in intervention effectiveness between participants who had experienced IPV at baseline and those who had not (*p* = 0.111).

10.1371/journal.pmed.1002166.t004

###### Comparison of intervention effectiveness in participant subgroups.
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   Subgroup                                                                       HIV Testing Uptake, Number/Total Number (Percent)   Effect of Self-Testing   *p*-Value for Interaction[\*\*](#t004fn002){ref-type="table-fn"}             
  ------------------------------------------------------------------------------- --------------------------------------------------- ------------------------ ------------------------------------------------------------------ --------- ---------
  **Study site**                                                                                                                                                                                                                            
  Urban health clinic                                                             80/120 (66.7)                                       117/129 (90.7)           24.0 (14.2 to 33.9)                                                \<0.001   ---
  Hospital                                                                        47/122 (38.5)                                       97/105 (92.4)            53.9 (43.8 to 63.9)                                                \<0.001   \<0.001
  Peri-urban health clinic                                                        21/44 (47.7)                                        44/50 (88.0)             40.3 (22.9 to 57.7)                                                \<0.001   0.093
  **Partner tested for HIV in 12 mo prior to enrollment**                                                                                                                                                                                   
  Tested ≥1 time                                                                  102/173 (59.0)                                      142/149 (95.3)           36.3 (28.3 to 44.4)                                                \<0.001   ---
  Did not test                                                                    16/35 (45.7)                                        37/42 (88.1)             42.4 (23.1 to 61.7)                                                \<0.001   0.389
  Do not know if tested                                                           30/73 (38.5)                                        79/93 (84.9)             46.5 (33.5 to 59.5)                                                \<0.001   0.057
  **Participants reported intimate partner violence in past 12 mo at baseline**                                                                                                                                                             
  No                                                                              114/210 (54.3)                                      185/206 (89.8)           35.5 (27.6 to 43.4)                                                \<0.001   ---
  Yes                                                                             34/76 (44.7)                                        73/78 (93.6)             48.9 (36.4 to 61.3)                                                \<0.001   0.111

\*Estimates and confidence intervals are marginal effects from a modified Poisson regression of outcome on study group for the subgroup described.

\*\**p*-Value for interaction coefficient between subgroup and first category (urban health clinic, tested ≥1 time in past 12 mo, and no IPV).

Discussion {#sec023}
==========

Provision of multiple self-tests to women led to secondary distribution of the self-tests to their male partners and ultimately achieved higher HIV testing among their male partners and higher couples testing than a more conventional approach of giving women invitation cards for their male partners to test at health facilities. In the group that received multiple self-tests, partner testing was reported by 91% of participants who were followed up, and 75% of participants followed up tested together with their partner. To our knowledge, this is the first randomized trial to test whether provision of multiple self-tests to women promotes partner and couples testing. In subgroup analyses, the intervention was more effective than the partner invitation approach even among women who reported a history of IPV at baseline and among women whose partners had not gone for HIV testing in the past 12 mo.

Male partner testing was nearly universal among women who received multiple self-tests. This striking result is consistent with findings from a pilot study we previously conducted in the study region, in which male partner testing was reported to have occurred for 91% of women seeking ANC and 86% of women receiving PNC \[[@pmed.1002166.ref022]\]. The study results are also consistent with the high acceptability of HIVST that has been documented throughout SSA and elsewhere \[[@pmed.1002166.ref015]--[@pmed.1002166.ref017]\].

Uptake of partner testing and couples testing in the comparison group that received invitation cards for their male partner was largely similar to what has been reported in two other recent studies. One study conducted in the same region of Kenya reported that couples testing occurred among 36% of pregnant women who received clinic invitation cards for their partner \[[@pmed.1002166.ref026]\]. Further, a study conducted among HIV-positive pregnant women in Malawi reported that couples testing occurred among 52% of women who received invitation cards for their partner \[[@pmed.1002166.ref027]\]. The similarity in male partner and couples testing levels in the comparison group of our study with those reported in these other studies of the partner invitation approach provide further support for the validity of the self-reported measures obtained in our study. In addition, it is notable that the couples testing rate in the HIVST group of our study was similar to or exceeded the rates achieved by the interventions tested in the two other studies: home visits and invitations followed by home tracing. While formal cost-effectiveness analyses are necessary, it is plausible that interventions relying on secondary distribution of self-tests would ultimately require fewer resources in total and therefore would have greater sustainability.

While prior HIV testing in this urban and peri-urban study setting was fairly high, we found no difference in the effectiveness of the HIVST intervention based on whether partners had tested for HIV in the past 12 mo. This result is encouraging since it suggests that the strategy of giving multiple self-tests to women can effectively increase access to HIV testing in hard-to-reach populations such as men who do not test regularly, and perhaps more generally in settings where testing rates are not as high as they were in our study setting. In addition, the large differences in partner testing between the HIVST and comparison groups was observed in all population subgroups, which suggests broader applicability of this intervention to various subgroups of pregnant and postpartum women.

From a policy standpoint, providing self-tests to women in clinic settings has substantial appeal not only because it promotes male partner testing but also because it helps women learn their partner's HIV status. The intervention's feasibility is enhanced by the fact that pregnant and postpartum women represent an easier-to-reach segment of the population by virtue of their higher utilization of health services. Couples testing, which is recommended by the World Health Organization and the Kenyan Ministry of Health, is another important benefit of the intervention. Individuals who test as a couple and mutually disclose their HIV status are more likely than those testing alone to adopt a range of HIV prevention and care behaviors \[[@pmed.1002166.ref005]\]. Despite these benefits, only 37.2% of people who have tested for HIV in Kenya reported ever testing together with a sexual partner \[[@pmed.1002166.ref028]\]. Notably, the uptake of couples testing observed among women given multiple self-tests in this study (75%) was higher than the uptake reported in the recent pilot study we conducted in the study area, in which women receiving ANC and PPC tested as couples 47% and 58% of the time, respectively \[[@pmed.1002166.ref022]\].

This study has several limitations that warrant discussion. First, we relied on self-reported data for the main outcomes. This is a common limitation in many studies involving HIVST due to the private manner in which self-tests are meant to be used. Despite the potential for self-reporting to be associated with reporting bias, we believe reporting bias was minimal given the above-mentioned consistency of our results for partner testing in both study groups with other studies conducted in SSA \[[@pmed.1002166.ref015],[@pmed.1002166.ref018],[@pmed.1002166.ref022],[@pmed.1002166.ref026],[@pmed.1002166.ref027]\] and given the lack of material incentives tied to participants' responses. In addition, any bias in reporting of testing uptake is unlikely to be differential by study group. Male partners in the comparison group were able to test at multiple facilities in the study area, and it was as difficult in practice to verify their clinic-based testing as it was to verify self-test usage by partners in the HIVST group. These factors are likely to strengthen the validity of comparing self-reported partner testing in the two study groups. Since objective verification of self-test use will remain a challenge, there is a need for larger-scale studies that examine downstream outcomes such as the proportion of partners linking to HIV prevention and treatment. Second, our study did not include women who knew their partner was HIV-positive because we believed that a partner testing intervention would have little additional benefit to them. This feature of the study design, coupled with high rates of HIV testing in the urban and peri-urban study setting \[[@pmed.1002166.ref029]\], likely led to relatively few HIV-positive partners being identified in this study. This limited our ability to make statistical inferences with respect to confirmatory testing and linkage to care. More research is needed to rigorously assess levels of confirmatory testing and linkage to care following HIVST, as well as to understand the decision-making process of whether or not to seek these services.

Finally, the third limitation stems from the fact that roughly one-third of women seeking ANC or PPC declined to participate in the study, and some were ineligible because they reported a fear that violence would result from offering a self-test to their partner. Among women declining participation, the most commonly reported reason was a lack of adequate time to enroll in the study, but other reasons such as a lack of interest in partner testing likely played a role. While these two reasons for declining to participate in the study do not impact the internal validity of the study results, they do limit the generalizability of the findings to all pregnant and postpartum women. Refusal also reinforces the feasibility and safety of offering multiple self-tests because women demonstrated considerable agency and ability to decide themselves whether to accept self-tests and offer them to their partner. Prior work has documented the high acceptability of this intervention among women receiving multiple self-tests \[[@pmed.1002166.ref022]\], and ongoing qualitative research with women receiving multiple self-tests shows that women have a strong sense of agency when deciding whether to offer self-tests to others and appreciate the opportunity to learn their partner's status. Additional qualitative research will provide insights and lessons for wider implementation. Given the novelty of HIVST and this particular strategy for promoting partner testing (i.e., secondary distribution of self-tests by women receiving ANC and PPC), it is also likely that the broader acceptability of secondary distribution strategies will grow as HIVST becomes more common. Additional research is necessary to assess the effectiveness of the intervention in other populations and settings outside western Kenya. However, to the extent that men experience similar barriers to clinic-based HIV testing elsewhere, the results from this study could be applicable to other settings and populations.

One concern about providing multiple self-tests to women for distribution to partners has been the possibility of IPV. Despite women reporting high rates of IPV in the past 12 mo at baseline (27%), it is noteworthy that the intervention was highly effective even among women who reported a history of IPV at baseline, and there were no cases of IPV due to HIV testing reported in either study group during the follow-up period. Few male partners had a reactive self-test result in the study, which may have contributed to the lack of reported IPV due to testing. However, prior research we have conducted with women receiving multiple self-tests---including female sex workers who identified a greater proportion of HIV-positive partners than ANC or PPC women in our study---also suggests IPV is rare \[[@pmed.1002166.ref022]\]. The fact that there were no cases of IPV also suggests that women have the agency and discretion to decide whether to accept self-tests and whether to offer self-tests to their partner.

This study provides key insights on a strategy---secondary distribution of self-tests to sexual partners---that may become common in many populations in SSA and elsewhere as HIV self-tests become more widely available, whether formally endorsed or not. For example, the feasibility of this approach is also being explored among key populations such as men who have sex with men \[[@pmed.1002166.ref030],[@pmed.1002166.ref031]\]. The promising results from this study suggest that secondary distribution of self-tests warrants further consideration as countries develop HIVST policies and seek new ways to promote partner testing. Implementing this intervention at scale is feasible as the primary requirements are that clinic staff be trained on how to explain self-test use and to offer self-tests to women. However, there are potential challenges to programmatic implementation of the intervention, such as ensuring adequate counseling when self-tests are offered to women, making counseling available post-test, and including interventions to achieve high linkage to appropriate services. Ongoing and planned implementation research will assess these issues and further develop strategies for maximizing the potential for HIVST in achieving HIV prevention and care objectives.
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